8-K
Crisp Momentum Inc. (CRSF)
As Filed with the Commission on March 5, 2021
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): March 4, 2021
W TECHNOLOGIES, INC.
(Name of registrant as specified in its Charter)
| Delaware | 000-24520 | 04-3021770 |
|---|---|---|
| (State or other jurisdiction | (Commission | (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 9440 Santa Monica Blvd., Suite 301, Beverly Hills CA | 90210 | |
| --- | --- | |
| (Address of principal executive offices) | (Zip Code) |
(424) 522-9977
(Registrant’s telephone number, including area code)
(Former name if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| COMMON STOCK | WTCG | OTCPK |
| ITEM 5.02 | DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS, ELECTION OF DIRECTOR, APPOINTMENT OF CERTAIN OFFICERS; COMPENSATION ARRANGEMENTS OF CERTAIN OFFICERS. |
|---|
Dr. Edward White was appointed to Registrant’s Board of Directors , effective as of March 8, 2021. See Exhibit 99.1 From March 2015 to the present, Dr. White has been a consultant to Comprehensive family medical care, at the American Hospital Dubai Clinics with emphasis on urgent/acute care in the emergency department setting; and with family medical care, emphasis on chronic and acute problems in the adult population in the Media City Clinic, while keeping abreast of latest medical practice and trends. From November 2010 to October 2014, he oversaw the provision of medical care covering over 32,000 lives in support of various international locations using US trained medical providers. From December 2009 to February 2011, he was in a comprehensive family practice, including surgical procedures, in the outpatient setting with a 100 physician medical clinic utilizing EPIC electronic medical record (EMR). From April 2007 until February 2009, he was a family physician in the US Army.
| ITEM 8.01 | OTHER EVENTS. |
|---|
On March 4, 2021, Registrant issued a press release announcing the appointment of Dr. Edward White MD, as a director of Registrant, effective March 8, 2021. See Exhibit 99.1.
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS. |
|---|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| W Technologies, Inc. | |
|---|---|
| Dated: March 5, 2021 | By: /s/ Mikael Lundgren |
| Name: Mikael Lundgren | |
| Title: President |
ex_231805.htm
Exhibit 99.1
W TECHNOLOGIES, INC.
Dr. Edward White Appointed to the Board of Directors of
W Technologies, Inc.
Beverly Hills, CA, March 4, 2021
W Technologies, Inc ., (“W Tech or the Company”), ( OTC : WTCG ) announced today that Dr. Edward White will join the Board of Directors, effective on March 8, 2021.
By Dr. White joining our Board, W Technologies will benefit because of his extensive knowledge and experience in the medical field said Mikael Lundgren, CEO of W Tech.
Dr. White currently is a consultant in Family Practice and in Emergency Room Practice at the American Hospital in Dubai and is the owner of Princeton Medical Solutions. Dr. White has also served with the US Army Medical Corp for almost six years. He holds a DEA License for controlled substances.
About W Technologies, Inc.
At this time, the Company’s purpose is to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to it by persons or firms who or which desire to seek the perceived advantages of an Exchange Act registered corporation. The Company will not restrict its search to any specific business, industry or geographical location and the Company may participate in a business venture of virtually any kind or nature. This discussion of the proposed business is purposefully general and is not meant to be restrictive of the Company’s virtually unlimited discretion to search for and enter into potential business opportunities.
The Company is continuing the review of several opportunities, especially in the field of medical CBD, with the intent to roll up into the Company any situation which results, after extensive review and due diligence, into a signed deal which can be consummated as a roll-up. The Company expects to have more information about specific situations within the next 30 days.
Forward-Looking Statements
Certain statements contained in this press release contain forward-looking statements within the meaning of the U.S. securities laws. Words such as “may,” “would,” “could,” “should,” “potential,” “will,” “seek,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions as they relate to the Company, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, based on information available to the Company, and are subject to certain risks, uncertainties and assumptions. While forward-looking statements are based on data, assumption and analyses that the Company believes are reasonable under the circumstances, whether actual results, performance or developments will meet the Company’s expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of the Company to differ materially from its expectations. Certain of the “risk factors” that could cause actual results to differ materially from the Company’s forward-looking statements, if any, in this press release include, without limitation; general economic, market and business conditions and factors, including the risk factors discussed or referred to in the Company’s Form 10 Registration Statement as filed with the U.S. Securities and Exchange Commission and available at www.sec.gov. Should any factor affect the Company in an unexpected manner or should assumptions underlying any such forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward look information. The forward-looking information included in this press release is made as of the date of this press release, and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
CONTACT INFORMATION
W Technologies, Inc.
Mikael Lundgren, CEO
Tel: 424 522 9977